Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Biomed Pharmacother ; 94: 481-488, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28779710

ABSTRACT

Annona muricata, locally known as soursop has been reported to exhibit antiproliferative activities against various cancer cell lines. In this current study, we have investigated the antitumor promotion of various fractions of Annona muricata leaves (AML); hexane (AMLH), dichloromethane (AMLD) and methanol (AMLM) fraction respectively on 7, 12-dimethylbenz[α]anthracene (DMBA) induced and 12-0-tetradecaboylphorbol-13-acetate (TPA) promoted skin tumorigenesis in mice via morphological assessment, biochemical analysis and histopathological evaluation. The results of the study revealed significant inhibition in tumor incidence, tumor burden and tumor volume in the groups received AMLH and AMLD, respectively, and suppressive effects in group received AMLM compared with carcinogen control group at week 21. Superoxide dismutase, catalase, and lipid peroxidation levels were returned to near normal by administration of AML to DMBA/TPA-induced mice. The above findings were supported by histopathological studies, in which the extensive epidermal hyperplasia in carcinogen control group was restored to normal in AML treated groups. Whilst, annonacin, a major annaonaceous acetogenin was found to be the highest in AMLH and AMLD. From the present study, it can be inferred that AML supressed DMBA/TPA-induced skin tumor and this antitumor-promoting activity may be linked to the antioxidant/free radical-scavenging constituents of the extract and annonacin contained in the extracts.


Subject(s)
Annona/chemistry , Antioxidants/metabolism , Carcinogenesis/pathology , Plant Extracts/therapeutic use , Plant Leaves/chemistry , Skin Neoplasms/drug therapy , Skin Neoplasms/prevention & control , 9,10-Dimethyl-1,2-benzanthracene , Administration, Topical , Animals , Carcinogenesis/drug effects , Furans/analysis , Lactones/analysis , Male , Mice, Inbred ICR , Plant Extracts/pharmacology , Skin/drug effects , Skin/pathology , Skin Neoplasms/enzymology , Tetradecanoylphorbol Acetate
2.
J Cancer Res Ther ; 8(3): 404-10, 2012.
Article in English | MEDLINE | ID: mdl-23174723

ABSTRACT

CONTEXT: Ardisia crispa Thunb. A. DC (Myrsinaceae) or locally known as hen's eyes has been used in local folk medicine as a remedy in various illnesses. Previously, it has been reported to inhibit various inflammatory diseases. However, research done on this plant is still limited. AIMS: In the present study, the hexane fraction of the A. crispa root (ACRH) was evaluated on the peri-initiation and promotion phases of skin carcinogenesis. MATERIALS AND METHODS: This two-stage skin carcinogenesis was induced by a single topical application of 7,12-dimethylbenz(α)anthracene (DMBA) and promoted by repeated treatment with croton oil for 10 weeks in Imprinting Control Region (ICR) mice. Morphological observation would be conducted to measure tumor incidence, tumor burden, and tumor volume. Histological evaluation on the skin tissue would also be done. RESULTS: The carcinogen control group exhibited 66.67% of tumor incidence. Although, in the ACRH-treated groups, at 30 mg/kg, the mice showed only 10% of tumor incidence with a significant reduction (P < 0.05) in the values of tumor burden and tumor volume of 2.00 and 0.52 mm(3), respectively. Furthermore, the result was significantly lower than that of the carcinogen and curcumin control. At 100 mg/kg, ACRH showed a comparable result to carcinogen control. On the contrary, at 300 mg/kg, ACRH exhibited 100% tumor incidence and showed a significant elevated (P < 0.05) value of tumor burden (3.80) and tumor volume (14.67 ± 2.48 mm(3)). CONCLUSIONS: The present study thus demonstrates that the anti-tumor effect of the chemopreventive potential of ACRH is at a lower dosage (30 mg/kg bwt) in both the initiating and promotion period, yet it exhibits a promoting effect at a higher dosage (300 mg/kg bwt).


Subject(s)
Ardisia/metabolism , Papilloma/drug therapy , Papilloma/prevention & control , Skin Neoplasms/drug therapy , Skin Neoplasms/prevention & control , 9,10-Dimethyl-1,2-benzanthracene , Animals , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Cell Transformation, Neoplastic/chemically induced , Cell Transformation, Neoplastic/drug effects , Chemoprevention , Croton Oil , Curcumin/pharmacology , Lipid Peroxidation/drug effects , Male , Medicine, Traditional , Mice , Mice, Inbred ICR , Papilloma/chemically induced , Phytotherapy , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Reactive Oxygen Species , Skin Neoplasms/chemically induced
SELECTION OF CITATIONS
SEARCH DETAIL
...